Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
To evaluate the visual outcome and number of injections required during an optical coherence
tomography (OCT)-guided treat and extend regimen with intravitreal aflibercept for treatment
of subfoveal neovascular age-related macular degeneration (NVAMD).